Julie Torode

1.8k total citations
31 papers, 668 citations indexed

About

Julie Torode is a scholar working on Oncology, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Julie Torode has authored 31 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Economics and Econometrics and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Julie Torode's work include Global Cancer Incidence and Screening (15 papers), Economic and Financial Impacts of Cancer (13 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Julie Torode is often cited by papers focused on Global Cancer Incidence and Screening (15 papers), Economic and Financial Impacts of Cancer (13 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Julie Torode collaborates with scholars based in United Kingdom, United States and India. Julie Torode's co-authors include Richard Sullivan, M. Saar, Nathan I. Cherny, Alexandru Eniu, Lisa Stevens, André Ilbawi, Gϋnter von Minckwitz, Andreas Schneeweiß, Sonali Johnson and J. Hilfrich and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Julie Torode

29 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Torode United Kingdom 10 365 255 134 105 89 31 668
Joseph C. Del Paggio Canada 13 248 0.7× 384 1.5× 66 0.5× 126 1.2× 93 1.0× 28 796
Aju Mathew United States 15 407 1.1× 113 0.4× 126 0.9× 152 1.4× 78 0.9× 64 773
Temidayo Fadelu United States 11 359 1.0× 109 0.4× 78 0.6× 78 0.7× 87 1.0× 36 611
Jaclyn Beca Canada 15 284 0.8× 251 1.0× 53 0.4× 204 1.9× 83 0.9× 58 691
Rosa Giuliani Italy 15 524 1.4× 105 0.4× 103 0.8× 128 1.2× 58 0.7× 31 805
Christine M. Bestvina United States 13 495 1.4× 243 1.0× 43 0.3× 315 3.0× 109 1.2× 65 966
Klazien Matter‐Walstra Switzerland 16 311 0.9× 166 0.7× 28 0.2× 178 1.7× 56 0.6× 40 580
Tallal Younis Canada 15 331 0.9× 77 0.3× 93 0.7× 118 1.1× 80 0.9× 34 577
Deme Karikios Australia 15 290 0.8× 125 0.5× 59 0.4× 284 2.7× 54 0.6× 50 646
N.J. Latino Israel 10 295 0.8× 301 1.2× 45 0.3× 185 1.8× 90 1.0× 17 654

Countries citing papers authored by Julie Torode

Since Specialization
Citations

This map shows the geographic impact of Julie Torode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Torode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Torode more than expected).

Fields of papers citing papers by Julie Torode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Torode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Torode. The network helps show where Julie Torode may publish in the future.

Co-authorship network of co-authors of Julie Torode

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Torode. A scholar is included among the top collaborators of Julie Torode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Torode. Julie Torode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pramesh, C.S., T. Peter Kingham, Miriam Mutebi, et al.. (2024). Quality indicators in surgical oncology: systematic review of measures used to compare quality across hospitals. BJS Open. 8(2). 3 indexed citations
2.
Torode, Julie, Nirmala Bhoo‐Pathy, Christopher M. Booth, et al.. (2024). Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study. The Lancet Oncology. 25(2). e63–e72. 8 indexed citations
3.
Mutebi, Miriam, Grant Lewison, Deborah Mukherji, et al.. (2024). Sex and authorship in global cancer research. SHILAP Revista de lepidopterología. 3(1). e000200–e000200.
4.
Fox, Louis, Aida Santaolalla, Richard Sullivan, et al.. (2023). Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post–COVID-19 Global Context: A Modified Delphi Consensus Process. JCO Global Oncology. 9(9). e2300111–e2300111. 1 indexed citations
5.
Sullivan, Richard, Grant Lewison, Julie Torode, et al.. (2022). Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement. The Lancet Oncology. 23(4). 460–462. 4 indexed citations
6.
Ritchie, David, Marc Arbyn, Partha Basu, et al.. (2021). Europe's path to eliminating cervical cancer as a public health problem. The Lancet Regional Health - Europe. 12. 100276–100276. 3 indexed citations
7.
Mukherji, Deborah, Raúl Murillo, Mieke Van Hemelrijck, et al.. (2021). Global cancer research in the post-pandemic world. The Lancet Oncology. 22(12). 1652–1654. 16 indexed citations
8.
Lewison, Grant, Ping Guo, Richard Harding, et al.. (2020). Cancer research in the 57 Organisation of Islamic Cooperation (OIC) countries, 2008–17. ecancermedicalscience. 14. 1094–1094. 4 indexed citations
9.
Ortmann, Olaf, Julie Torode, Wolff Schmiegel, et al.. (2020). Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany. Journal of Cancer Research and Clinical Oncology. 146(7). 1813–1818. 2 indexed citations
11.
Ortmann, Olaf, Julie Torode, Sakari Karjalainen, et al.. (2018). Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany. Journal of Cancer Research and Clinical Oncology. 144(6). 1097–1102. 2 indexed citations
12.
Trapani, Dario, Sonali Johnson, Leslie Given, et al.. (2018). National cancer control plans: a global analysis. The Lancet Oncology. 19(10). e546–e555. 120 indexed citations
13.
Cherny, Nathan I., Richard Sullivan, Julie Torode, M. Saar, & Alexandru Eniu. (2017). ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Annals of Oncology. 28(11). 2633–2647. 84 indexed citations
14.
Zujewski, Jo Anne, Allison Dvaladze, André Ilbawi, et al.. (2017). Knowledge Summaries for Comprehensive Breast Cancer Control. Journal of Global Oncology. 4(4). 1–7. 16 indexed citations
15.
Cherny, Nathan I., Richard Sullivan, Julie Torode, M. Saar, & Alexandru Eniu. (2016). ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Annals of Oncology. 27(8). 1423–1443. 121 indexed citations
16.
Ortmann, Olaf, et al.. (2015). Improving cancer care in Europe: Which institutional health structures might be beneficial and why? 1. European Roundtable Meeting (ERTM), 16th May 2014, Berlin, Germany. Journal of Cancer Research and Clinical Oncology. 142(1). 1–4. 14 indexed citations
18.
Azenha, Gustavo S., Afsan Bhadelia, Alessandra Durstine, et al.. (2013). Recommendations towards an integrated, life-course approach to women’s health in the post-2015 agenda. Bulletin of the World Health Organization. 91(9). 704–706. 14 indexed citations
19.
Minckwitz, Gϋnter von, W. Jonat, Peter A. Fasching, et al.. (2005). A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer. Breast Cancer Research and Treatment. 89(2). 165–172. 128 indexed citations
20.
Schneeweiß, Andreas, Sebastian Aulmann, Gϋnter von Minckwitz, et al.. (2004). Induction of remission in a patient with metastatic breast cancer refractory to trastuzumab and chemotherapy following treatment with gefitinib (‘Iressa’, ZD1839). Anti-Cancer Drugs. 15(3). 235–238. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026